MiMedx (MDXG) CFO awarded new stock options and restricted shares

Rhea-AI Filing Summary

MiMedx Group Chief Financial Officer Doug Rice received new equity awards in the form of stock options and restricted stock. On March 4, 2026, he was granted 62,068 stock options at an exercise price of $0.00 per share and 74,163 shares of common stock as a restricted stock grant.

The stock options vest in four equal annual installments of 25% on each anniversary of the grant date, contingent on his continued employment under the Nonqualified Stock Option Agreement. The restricted stock vests fully on the third anniversary of the grant date, also subject to continued employment under the Restricted Stock Unit Agreement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DOUG RICE

(Last) (First) (Middle)

1775 WEST OAK COMMONS COURT NE

(Street)

MARIETTA GA 30062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		A		74,163(1)	A	$0	265,678(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$5.1	03/04/2026		A		62,068		(3)	03/03/2033	Common Stock	62,068	$0	263,309	D

Explanation of Responses:

1. Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

2. Includes 3,491 shares acquired on January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.

3. The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

Remarks:

	William F. Hulse, as attorney-in-fact for Doug Rice	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MiMedx (MDXG) CFO Doug Rice report in this Form 4 filing?

Doug Rice reported equity awards from MiMedx Group, Inc. He received 62,068 stock options and 74,163 restricted shares of common stock as grants, with both awards subject to multi-year vesting tied to continued employment.

How many stock options were granted to the MiMedx (MDXG) CFO and how do they vest?

The CFO received 62,068 stock options in this transaction. These options vest 25% on each anniversary of the March 4, 2026 grant date, over four years, assuming he remains employed under the Nonqualified Stock Option Agreement terms.

What restricted stock did the MiMedx (MDXG) CFO receive in this Form 4?

The CFO received 74,163 shares of restricted common stock from MiMedx Group, Inc. This restricted stock vests in full on the third anniversary of the March 4, 2026 grant date, conditioned on his continued employment under the Restricted Stock Unit Agreement.

Were the MiMedx (MDXG) CFO’s equity awards open-market purchases or grants?

The reported transactions are equity grants, not open-market purchases. Both the 62,068 stock options and 74,163 restricted shares were awarded at a reported price of $0.00 per share as part of compensation arrangements.

What does the MiMedx (MDXG) Form 4 say about the CFO’s employment conditions?

The filing links vesting of both awards to continued employment. Stock options vest annually under a Nonqualified Stock Option Agreement, and restricted shares vest after three years under a Restricted Stock Unit Agreement, each requiring the CFO to remain employed through the relevant dates.

Does the MiMedx (MDXG) Form 4 mention other recent share acquisitions by the CFO?

Yes. A footnote notes that the CFO’s holdings include 3,491 shares acquired on January 30, 2026 under the MiMedx Group, Inc. Employee Stock Purchase Plan, in addition to the equity awards reported in this Form 4.